Please login to the form below

Not currently logged in
Email:
Password:

Ferring agrees Chinese reproductive medicine research deal

Work with the Chinese Academy of Sciences on the long-term project

Ferring

Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) are set to collaborate on a long-term project to advance basic and translational research in reproductive medicine.

The project will see the duo develop novel product candidates and therapeutic strategies in a jointly funded laboratory based in the CAS research facility in Beijing, China.

Known as the ‘Ferring Institute of Reproductive Medicine’, the facility will bring together researchers from both Ferring and CAS to find solutions that will address global challenges in fertility and high rates of obstetric complications.

Per Falk, executive vice president and chief scientific officer of Ferring Pharmaceuticals, said: “Across the world too many couples still face considerable challenges when trying to become families.

“This collaboration forms the next phase in our ongoing effects to advance knowledge and care in reproductive medicine and women’s health.”

The pharmaceutical group has said that they hope to gain a deeper understanding of fertility and implantation, with the aim of discovering new solutions.

Professor Hongemi Wang, director of the state key laboratory, CAS, said: “Our collaboration with Ferring will expand our research base into the translational space and together we will rapidly expand our tool set to look at truly transformational ideas in reproductive medicines.”

CAS has an additional interest in the collaboration, as it will provide expertise and funding to support their stem cell research and regenerative medicine, a core element of their Innovation 2030: Building Tomorrow initiative, which aims to improve reproductive health both in China and worldwide.

Article by
Gemma Jones

12th January 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics